Form 4: Gilead Sciences Director Sandra Horning Reports Stock Option and Restricted Stock Unit Grant

Director Sandra Horning reports the acquisition of stock options and restricted stock units in Gilead Sciences, Inc.

Summary

• On May 8, 2024, Sandra Horning, a director of Gilead Sciences, Inc., was granted 12,648 non-qualified stock options with an exercise price of $64.92, which vest immediately.
• Horning also received 2,310 restricted stock units, each representing the right to receive one share of Gilead Sciences, Inc.'s common stock, which also vested immediately on the grant date.
• Following these transactions, Horning directly owns 12,648 derivative securities and 7,801 shares.
• The report was filed on May 9, 2024.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, indicating confidence in the director and the company's future, but does not contain any groundbreaking news.

Positives

• The immediate vesting of both the stock options and restricted stock units suggests confidence in the director's continued service and the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the grant of stock options and restricted stock units suggests an expectation of continued contributions from the director and alignment with shareholder interests.

Industry Context

Stock option and restricted stock unit grants are common forms of executive compensation in the pharmaceutical industry, aligning management's interests with those of shareholders and incentivizing long-term value creation. This is a standard practice to retain and motivate key personnel.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the pharmaceutical industry, similar to companies like Amgen (AMGN) and Johnson & Johnson (JNJ).
• The vesting schedule (immediate in this case) can vary, with some companies using graded vesting over several years to further incentivize long-term commitment.
• The size of the grant is relative to the director's role and the company's overall compensation strategy, which is generally benchmarked against peer companies.

Stakeholder Impact

• The grant of stock options and restricted stock units aligns the director's interests with those of shareholders, incentivizing decisions that increase shareholder value.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates